EICHOR
● Recruiting
Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy
Condition: Knee Osteoarthritis · Sponsor: Aarhus University Hospital
About this study
This phase I and II double blinded randomized clinical controlled trial investigates the safety and efficacy of intraarticular knee injection with allogenic adipose derived mesenchymal stem cells (AD-MSC), in patients suffering from mild-moderate knee osteoarthritis compared to placebo injection with saline.
This description comes directly from the study's public registry record.
Talk to the study team
Rasmus Aabling, MD · +4528496767 · rasaab@clin.au.dk
Michael Pedersen, Professor · michael@clin.au.dk
Always discuss trial participation with your own doctor first.
Locations (1)
| Aarhus University | Aarhus N, Denmark | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05933434